Background: CCN1/CYR61 is a matricellular protein belonging to CCN protein family that contains
six secreted proteins associated with extracellular matrix signaling [1]. It acts
as an enhancer of cutaneous wound healing process by preventing hypertrophic scar
formation through induction of myofibroblast (MFB) senescence [2]. In liver fibrosis,
senescent cells are primarily derived from activated hepatic stellate cells (HSC)
that initially proliferate in response to liver damage and transdifferentiate into
MFB. Activated HSC and transdifferentiated MFB are one major source of CCN1 [3]. Methods: We tested if CCN1 act as a senescence inducer to attenuate liver fibrogenesis by
means of adenoviral CCN1 gene transfer in primary HSC, MFB, CFSC-2G, and LX-2. Results: The overwhelming concentrations of CCN1 protein resulted in an overload of the endoplasmic
reticulum (ER) and compensatory unfolded protein response (UPR) in all these cells.
The UPR resulted in upregulation of ER chaperones (BIP/Grp78, Grp94) and leads to
an activation of IRE1α as evidenced by spliced XBP1 mRNA with IRE1α-induced JNK phosphorylation.
The UPR arm PERK and eIF2a was phosphorylated, and CHOP upregulated. Ad5-CMV-CCN1
induced HSC apoptosis by proteolytic cleavage of caspase-12, caspase-9, and caspase-3
resulting in positive TUNEL stain. Remarkably, CCN1 effectively blocked collagen type
I expression at both mRNA and protein levels. Conclusions: High concentrations of the matricellular protein CCN1 induce HSC apoptosis through
ER stress and UPR. Therapeutic CCN1 gene transfer might be useful to mitigate liver
fibrosis when cell-specific targeted to HSC and MFB.
References cited:
[1] Weiskirchen R. Front Biosci 2011;16:1939 – 61.
[2] Jun JI & Lau LF. Nat Cell Biol 2010;12:676 – 85.
[3] Borkham-Kamphorst E et al. Biochim Biophys Acta 2014;1843:902 – 14.
Corresponding author: Weiskirchen, Ralf
E-Mail:
rweiskirchen@ukaachen.de